Pt. Prodia Stem Cell Indonesia
Clinical trials sponsored by Pt. Prodia Stem Cell Indonesia, explained in plain language.
-
Stem cell therapy for rare eye disease passes 5-year safety check
Disease control Not yet recruitingThis study follows up 18 people who received umbilical cord stem cells or conditioned medium for retinitis pigmentosa, a rare eye disease that causes vision loss. Researchers will check vision, eye structure, and safety five years after the injection. The goal is to see if the tr…
Sponsor: PT. Prodia Stem Cell Indonesia • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Could stem cells save sight? new trial tests umbilical cord therapy for eye disease
Disease control Not yet recruitingThis study tests whether stem cells from umbilical cord tissue can safely slow vision loss in people with retinitis pigmentosa, an inherited eye disease. Thirty participants will receive one of two doses injected around the eye and be monitored for six months. The main goals are …
Phase: PHASE2, PHASE3 • Sponsor: PT. Prodia Stem Cell Indonesia • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC